Latest News & Updates

Breaking News

  • 6 hours ago

  • Pharma Now Editorial Team

Kyowa Kirin Secures Public Reimbursement for Burosumab in Four Canadian Provinces for Adult XLH
Breaking News
Cristcot Appoints Rayna Herman as President of Hydrocortisone Acetate Commercial Division Ahead of FDA Decision

Pharma Now Editorial Team

Other trending news you may like to read

Kyowa Kirin Secures Public Reimbursement for Burosumab in Four Canadian Provinces for Adult XLH

Kyowa Kirin secures public reimbursement for burosumab in four Canadian provinces and the federal NIHB program, closing a coverage gap for adults with XLH.

Pharma Now Editorial Team

Pharma Now

Cristcot Appoints Rayna Herman as President of Hydrocortisone Acetate Commercial Division Ahead of FDA Decision

Cristcot appoints Rayna Herman to lead its HCA commercial division as the company's ngHCA suppository remains under FDA review.

Pharma Now Editorial Team

Pharma Now

Parexel Acquires Vitrana to Expand AI-Powered Pharmacovigilance and Patient Safety Capabilities

Parexel acquires Vitrana to integrate AI-powered pharmacovigilance, reshaping safety reporting workflows for drug manufacturers and CRO partners.

Pharma Now Editorial Team

Pharma Now

Eli Lilly Gains Traditional FDA Approval for Selpercatinib in RET-Mutant Medullary Thyroid Cancer

FDA converts selpercatinib to traditional approval for RET-mutant MTC, with LIBRETTO-531 PFS data satisfying confirmatory evidence requirements.

Pharma Now Editorial Team

Pharma Now